Ipsen S.A. (IPSEF)
OTCMKTS · Delayed Price · Currency is USD
113.13
+9.63 (9.30%)
At close: Jun 9, 2025
Ipsen Market Cap
Ipsen has a market cap or net worth of $11.55 billion as of November 3, 2025. Its market cap has increased by 12.36% in one year.
Market Cap
11.55B
Enterprise Value
10.99B
Revenue
4.42B
Ranking
n/a
PE Ratio
21.96
Stock Price
$113.13
Market Cap Chart
Since December 7, 2005, Ipsen's market cap has increased from 2.08B to 11.55B, an increase of 454.82%. That is a compound annual growth rate of 8.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 11.55B | 21.88% |
| Dec 31, 2024 | 9.48B | -3.79% |
| Dec 29, 2023 | 9.85B | 11.34% |
| Dec 30, 2022 | 8.85B | 17.52% |
| Dec 31, 2021 | 7.53B | 9.75% |
| Dec 31, 2020 | 6.86B | -6.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 655.38M |
| Glass House Brands | 569.74M |
| Northwest Biotherapeutics | 366.55M |
| Silence Therapeutics | 345.28M |
| Nika Pharmaceuticals | 312.10M |
| American Oncology Network | 305.06M |
| CytoDyn | 302.34M |